Drug developed halted by formulation challenges, CMC issues, or pharmacokinetic deficiencies can feel like the program has slid back down to the bottom of a mountain. Our belief is the best solution is to examine these challenges with a fresh set of eyes, not bogged down by what has been attempted before.
“"One great advantage which inexperience confers on the would-be mountaineer is that he is not bogged down by tradition or precedence. To him all things appear simple and he chooses straight forward solutions to the problems he faces."”
Walt UnsworthEverest: The Mountaineering History
We work with clients to reformulate a drug to solve problems encountered during development or for abbreviated regulatory pathways such as the 505(b)(2) or sNDA pathways.
PARTNER WITH CALLAN PHARMA
Callan Pharma provides its partners rapid, comprehensive and cost-effective solutions for their difficult formulation development projects.